Oncology Central

Sodium thiosulphate halves hearing loss in children following cancer treatment

A study conducted by Cancer Research UK (London) has provided evidence that administering sodium thiosulphate (STS) after cisplatin chemotherapy reduced hearing loss by almost 50% in children treated for hepatoblastoma.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.